SCHEMBL7260290

SCHEMBL7260290

OCCCc1ccc(CNc2nc(NCc3cccs3)nc3ccc(Cl)cc23)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 7/20 0.54
HRH1 P35367 1/20 0.54
NPC1 O15118 1/20 0.47
HTR3A P46098 2/20 0.45
CLK4 Q9HAZ1 2/20 0.45
PDE5A O76074 4/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
USP2 O75604 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
APEX1 P27695 1/20 0.42
CYP2C19 P33261 1/20 0.42
CASP7 P55210 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7258507 0.85 HRH4 (0.55) HRH4HRH1NPC1HTR3ACLK4
SCHEMBL7254578 0.84 HRH4 (0.60) HRH4HRH1NPC1HTR3ACLK4
SCHEMBL7255652 0.84 HRH4 (0.55) HRH4HRH1NPC1HTR3ACLK4
SCHEMBL7258098 0.82 HRH1 (0.47) HRH4HRH1NPC1CLK4
SCHEMBL7259508 0.79 HRH4 (0.52) HRH4HRH1NPC1HTR3ACLK4
SCHEMBL7259297 0.79 HRH1 (0.50) HRH4HRH1
SCHEMBL2590769 0.76 RAD52 (0.68) HRH4HTR3APDE5AKMT2AALDH1A1
SCHEMBL7254519 0.75 NPC1 (0.52) HRH4HRH1NPC1CLK4MEN1
SCHEMBL21686898 0.70 HRH4 (1.00) HRH4HRH1HTR3A
SCHEMBL29870144 0.70 HRH4 (1.00) HRH4HRH1HTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003055866-A1 QUINAZOLINE AND QUINOLINE DERIVATIVE COMPOUNDS AS INHIBITORS OF PROLYLPEPTIDASE, INDUCERS OF APOPTOSIS AND CANCER TREATMENT AGENTS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-10 WO disclosed